GlassScriptPhysician profile
Luis A Bonilla
NPI 1154301265
$5,179.29
in general payments reported to CMS, 2019-2025
9 companies · $75.00 in 2025
The $75.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $175 · 2021: $945 · 2022: $1,373 · 2023: $2,283 · 2024: $106 · 2025: $75.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,537 · Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,537.01 |
| Food and Beverage | $926.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,849.77 | 2019-2023 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $397.65 | 2020-2022 | |
| Medtronic, INC. | $282.53 | 2023 | Gia |
| Johnson and Johnson International | $213.39 | 2019-2025 | Surgicel Nu-Knit, Enseal X1, Echelon Flex |
| Becton, Dickinson and Company | $195.46 | 2023 | Phasix Mesh, Sorbafix Absorbable Fixation System |
| Intuitive Surgical, INC. | $89.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $74.76 | 2019-2023 | Xarelto |
| Bard Access Systems, INC. | $59.56 | 2019 | |
| Chiesi USA, INC. | $16.75 | 2024 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Bonilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.